Literature DB >> 17085788

Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms.

Gary P Anderson1.   

Abstract

Beta2-adrenoceptors are widely, almost ubiquitously, expressed. Activation of these receptors on bronchial smooth muscle by short- and long-acting beta2-adrenoceptor agonists causes bronchodilation. Here, the beta2-adrenoceptor is linked by the G protein, Gs, to adenylyl cyclase, which increases cyclic adenosine monophosphate (cAMP), thus activating protein kinase A, which affects calcium levels and reduces the efficiency of myosin light-chain kinase, causing relaxation. Activation also entrains numerous acute and longer term downregulation responses affecting the number, location, and net efficiency of signaling of the receptor. Synthetic beta2-agonists are all "partial agonists," incompletely able to optimally stimulate cAMP signal transduction. However, compared with some cells (such as mast cells) involved in exercise- induced asthma induction, airway smooth muscle is privileged in that transduction efficiency is intrinsically high and the tissue is very resistant to complete downregulation. Glucocorticosteroids have broadly beneficial interactions with beta2-adrenoceptors. Researchers have recently discovered that the beta2-adrenoceptor may function as a homodimer and that it can form heterodimers with both the beta1- and beta3-adrenoceptors, and possibly other receptors. This further complicates interpretation of the effect of beta2-adrenoceptor polymorphisms, but it is unknown whether this occurs in humans in vivo. Researchers have known for some time that strong contraction involving receptors coupled to the Gq G protein (e.g., cholinergic and leukotriene receptors via negative biochemical crosstalk), virus infection (via uncoupling), and inflammation (via kinases) can impair relaxation. Most recently, researchers have discovered that the beta2-adrenoceptor can also send potentially adverse signals after "atypical coupling" to Gq rather than Gs. The clinical implications of these uncouplings, crosstalk, and atypical coupling possibilities are not well-understood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085788     DOI: 10.1385/CRIAI:31:2:119

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  79 in total

1.  Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Authors:  D R Taylor; J M Drazen; G P Herbison; C N Yandava; R J Hancox; G I Town
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

2.  Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.

Authors:  E H Ramsdale; J Otis; P A Kline; L S Gontovnick; F E Hargreave; P M O'Byrne
Journal:  Am Rev Respir Dis       Date:  1991-05

3.  A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

Authors:  J C Kips; B J O'Connor; M D Inman; K Svensson; R A Pauwels; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

Review 4.  Is there a problem with inhaled long-acting beta-adrenergic agonists?

Authors:  Harold S Nelson
Journal:  J Allergy Clin Immunol       Date:  2006-01       Impact factor: 10.793

Review 5.  Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.

Authors:  G P Anderson
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

6.  The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.

Authors:  Daniel K C Lee; Graeme P Currie; Ian P Hall; John J Lima; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

7.  The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo.

Authors:  S R O'Donnell; G P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.

Authors:  Ali Salahpour; Stéphane Angers; Jean-François Mercier; Monique Lagacé; Stefano Marullo; Michel Bouvier
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

9.  A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle.

Authors:  T R Bai; J C Mak; P J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  1992-06       Impact factor: 6.914

10.  Abnormalities in airway smooth muscle in fatal asthma. A comparison between trachea and bronchus.

Authors:  T R Bai
Journal:  Am Rev Respir Dis       Date:  1991-02
View more
  23 in total

1.  Albuterol modulates its own transepithelial flux via changes in paracellular permeability.

Authors:  Hoshang J Unwalla; Gabor Horvath; Felix D Roth; Gregory E Conner; Matthias Salathe
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

2.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

3.  Intracellular peptides as natural regulators of cell signaling.

Authors:  Fernanda M Cunha; Denise A Berti; Zulma S Ferreira; Clécio F Klitzke; Regina P Markus; Emer S Ferro
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

4.  Homology model and docking studies on porcine β₂ adrenoceptor: description of two binding sites.

Authors:  Marvin A Soriano-Ursúa; José Correa-Basurto; José G Trujillo-Ferrara; Alberto J Kaumann
Journal:  J Mol Model       Date:  2011-01-04       Impact factor: 1.810

5.  Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Authors:  Artur Wnorowski; Mariola Sadowska; Rajib K Paul; Nagendra S Singh; Anna Boguszewska-Czubara; Lucita Jimenez; Kotb Abdelmohsen; Lawrence Toll; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2015-02-20       Impact factor: 4.315

6.  Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: desensitization via the Y2-neuropeptide receptor.

Authors:  Jin Zhang; Susan T Halm; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

7.  An environmental epigenetic study of ADRB2 5'-UTR methylation and childhood asthma severity.

Authors:  A Fu; B P Leaderer; J F Gent; D Leaderer; Y Zhu
Journal:  Clin Exp Allergy       Date:  2012-08-03       Impact factor: 5.018

Review 8.  Regular treatment with salmeterol for chronic asthma: serious adverse events.

Authors:  Christopher J Cates; Matthew J Cates
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

9.  Adrenergic activation of electrogenic K+ secretion in guinea pig distal colonic epithelium: involvement of beta1- and beta2-adrenergic receptors.

Authors:  Jin Zhang; Susan T Halm; Dan R Halm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-05-21       Impact factor: 4.052

Review 10.  Regular treatment with formoterol for chronic asthma: serious adverse events.

Authors:  Christopher J Cates; Matthew J Cates
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.